nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—UGT1A9—Irinotecan—hematologic cancer	0.121	1	CbGbCtD
Entacapone—UGT1A9—Glucuronidation—UGT1A1—hematologic cancer	0.00204	0.0151	CbGpPWpGaD
Entacapone—UGT1A9—Estrogen metabolism—NQO1—hematologic cancer	0.00188	0.0139	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.00184	0.0136	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.00173	0.0128	CbGpPWpGaD
Entacapone—UGT1A9—Estrogen metabolism—GSTM1—hematologic cancer	0.00144	0.0106	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTO1—hematologic cancer	0.00137	0.0101	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.00135	0.00996	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUND—hematologic cancer	0.00129	0.00955	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—UGT1A1—hematologic cancer	0.00129	0.00955	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—UGT1A1—hematologic cancer	0.00129	0.00948	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—SLC35B2—hematologic cancer	0.00127	0.00938	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—SLC35B2—hematologic cancer	0.00124	0.00916	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—EPHX1—hematologic cancer	0.00122	0.00903	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.00112	0.00822	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—MTR—hematologic cancer	0.00112	0.00822	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTT1—hematologic cancer	0.00106	0.00782	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	0.000936	0.00691	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—NQO1—hematologic cancer	0.000887	0.00654	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	0.000886	0.00653	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—FHL2—hematologic cancer	0.000867	0.00639	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FHL2—hematologic cancer	0.000849	0.00626	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—CDK4—hematologic cancer	0.000847	0.00624	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HSP90AA1—hematologic cancer	0.000834	0.00615	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTO1—hematologic cancer	0.000819	0.00604	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTO1—hematologic cancer	0.0008	0.0059	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTO1—hematologic cancer	0.000789	0.00582	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—UGT1A1—hematologic cancer	0.00077	0.00568	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—ARNTL—hematologic cancer	0.000758	0.00559	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—UGT1A1—hematologic cancer	0.000752	0.00555	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—SLC35B2—hematologic cancer	0.000744	0.00549	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—UGT1A1—hematologic cancer	0.000742	0.00547	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ARNTL—hematologic cancer	0.000742	0.00547	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTP1—hematologic cancer	0.000735	0.00542	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—EPHX1—hematologic cancer	0.000734	0.00541	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR2—hematologic cancer	0.000712	0.00525	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—hematologic cancer	0.000684	0.00504	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTM1—hematologic cancer	0.000676	0.00498	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—MTR—hematologic cancer	0.000668	0.00493	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—BAX—hematologic cancer	0.000663	0.00489	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—MTR—hematologic cancer	0.000652	0.00481	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	0.000649	0.00478	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTT1—hematologic cancer	0.000635	0.00469	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTT1—hematologic cancer	0.00062	0.00458	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000594	0.00438	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—FHL2—hematologic cancer	0.000585	0.00431	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—NCOA3—hematologic cancer	0.000574	0.00424	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOA3—hematologic cancer	0.000562	0.00415	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—CCND1—hematologic cancer	0.000547	0.00403	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—ABCC3—hematologic cancer	0.000547	0.00403	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TXN—hematologic cancer	0.000547	0.00403	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000529	0.0039	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—UGT1A1—hematologic cancer	0.000514	0.00379	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ARNTL—hematologic cancer	0.000511	0.00377	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SLC22A1—hematologic cancer	0.000497	0.00367	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR2—hematologic cancer	0.000491	0.00362	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTO1—hematologic cancer	0.000479	0.00354	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTO1—hematologic cancer	0.000473	0.00349	CbGpPWpGaD
Entacapone—COMT—Neuronal System—ADCY7—hematologic cancer	0.000455	0.00336	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—UGT1A1—hematologic cancer	0.000451	0.00332	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—UGT1A1—hematologic cancer	0.000445	0.00328	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	0.000443	0.00327	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTP1—hematologic cancer	0.00044	0.00325	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—MYC—hematologic cancer	0.000439	0.00323	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTP1—hematologic cancer	0.00043	0.00317	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTP1—hematologic cancer	0.000424	0.00313	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—hematologic cancer	0.000423	0.00312	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	0.000405	0.00299	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CAMK2D—hematologic cancer	0.000405	0.00299	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTM1—hematologic cancer	0.000405	0.00298	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	0.0004	0.00295	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTM1—hematologic cancer	0.000395	0.00291	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—MTR—hematologic cancer	0.000391	0.00288	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTM1—hematologic cancer	0.00039	0.00287	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA3—hematologic cancer	0.000387	0.00286	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTT1—hematologic cancer	0.000372	0.00274	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	0.000363	0.00268	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	0.000357	0.00263	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	0.000355	0.00262	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—NQO1—hematologic cancer	0.000352	0.0026	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	0.000346	0.00255	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—NCOR1—hematologic cancer	0.000339	0.0025	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000334	0.00247	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—hematologic cancer	0.000331	0.00244	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—HSP90AA1—hematologic cancer	0.000331	0.00244	CbGpPWpGaD
Entacapone—COMT—Metabolism—GMPS—hematologic cancer	0.00033	0.00243	CbGpPWpGaD
Entacapone—COMT—Metabolism—FTCD—hematologic cancer	0.00033	0.00243	CbGpPWpGaD
Entacapone—COMT—Metabolism—PHYH—hematologic cancer	0.00033	0.00243	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	0.000319	0.00235	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	0.00031	0.00229	CbGpPWpGaD
Entacapone—COMT—Metabolism—SMPD3—hematologic cancer	0.000301	0.00222	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTP1—hematologic cancer	0.000294	0.00217	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000286	0.00211	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	0.000277	0.00204	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—HGF—hematologic cancer	0.00027	0.00199	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTM1—hematologic cancer	0.00027	0.00199	CbGpPWpGaD
Entacapone—COMT—Metabolism—B3GAT1—hematologic cancer	0.000263	0.00194	CbGpPWpGaD
Entacapone—COMT—Metabolism—ASNS—hematologic cancer	0.000263	0.00194	CbGpPWpGaD
Entacapone—COMT—Metabolism—DCK—hematologic cancer	0.000263	0.00194	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	0.000259	0.00191	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTP1—hematologic cancer	0.000258	0.0019	CbGpPWpGaD
Entacapone—COMT—Neuronal System—PRKCG—hematologic cancer	0.000256	0.00189	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTP1—hematologic cancer	0.000254	0.00187	CbGpPWpGaD
Entacapone—COMT—Metabolism—HDC—hematologic cancer	0.00025	0.00184	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000248	0.00183	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000244	0.0018	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTM1—hematologic cancer	0.000237	0.00175	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTM1—hematologic cancer	0.000234	0.00172	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—CREBBP—hematologic cancer	0.000233	0.00172	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.000233	0.00172	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—PDGFB—hematologic cancer	0.000232	0.00171	CbGpPWpGaD
Entacapone—COMT—Metabolism—CDA—hematologic cancer	0.000228	0.00168	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—hematologic cancer	0.000228	0.00168	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—hematologic cancer	0.000228	0.00168	CbGpPWpGaD
Entacapone—COMT—Metabolism—PC—hematologic cancer	0.00022	0.00162	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC35B2—hematologic cancer	0.000212	0.00157	CbGpPWpGaD
Entacapone—COMT—Metabolism—GBA—hematologic cancer	0.000212	0.00157	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000205	0.00151	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.000204	0.0015	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—FTCD—hematologic cancer	0.000197	0.00146	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PHYH—hematologic cancer	0.000197	0.00146	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GMPS—hematologic cancer	0.000197	0.00146	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.000195	0.00144	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTAP—hematologic cancer	0.000194	0.00143	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CREB1—hematologic cancer	0.00019	0.0014	CbGpPWpGaD
Entacapone—COMT—Neuronal System—BRAF—hematologic cancer	0.000187	0.00138	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.000186	0.00137	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.000184	0.00136	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SMPD3—hematologic cancer	0.000181	0.00133	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.00018	0.00133	CbGpPWpGaD
Entacapone—COMT—Metabolism—FHL2—hematologic cancer	0.000173	0.00128	CbGpPWpGaD
Entacapone—COMT—Metabolism—AGRN—hematologic cancer	0.00017	0.00125	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	0.000168	0.00124	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	0.000164	0.00121	CbGpPWpGaD
Entacapone—COMT—Metabolism—IDH2—hematologic cancer	0.000161	0.00119	CbGpPWpGaD
Entacapone—COMT—Metabolism—HMMR—hematologic cancer	0.000161	0.00119	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—EP300—hematologic cancer	0.000159	0.00117	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—DCK—hematologic cancer	0.000158	0.00116	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ASNS—hematologic cancer	0.000158	0.00116	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—B3GAT1—hematologic cancer	0.000158	0.00116	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—hematologic cancer	0.000157	0.00116	CbGpPWpGaD
Entacapone—COMT—Neuronal System—MDM2—hematologic cancer	0.000157	0.00116	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—hematologic cancer	0.000155	0.00115	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	0.000154	0.00114	CbGpPWpGaD
Entacapone—COMT—Metabolism—ARNTL—hematologic cancer	0.000151	0.00112	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HDC—hematologic cancer	0.00015	0.0011	CbGpPWpGaD
Entacapone—COMT—Metabolism—ACP5—hematologic cancer	0.000147	0.00109	CbGpPWpGaD
Entacapone—COMT—Metabolism—CA9—hematologic cancer	0.000147	0.00109	CbGpPWpGaD
Entacapone—COMT—Metabolism—NCOR2—hematologic cancer	0.000145	0.00107	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	0.00014	0.00103	CbGpPWpGaD
Entacapone—COMT—Metabolism—IDH1—hematologic cancer	0.000138	0.00102	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CDA—hematologic cancer	0.000137	0.00101	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCC3—hematologic cancer	0.000137	0.00101	CbGpPWpGaD
Entacapone—COMT—Metabolism—TXN—hematologic cancer	0.000137	0.00101	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTO1—hematologic cancer	0.000137	0.00101	CbGpPWpGaD
Entacapone—COMT—Metabolism—SPHK1—hematologic cancer	0.000134	0.000988	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PC—hematologic cancer	0.000132	0.000971	CbGpPWpGaD
Entacapone—COMT—Metabolism—UGT1A1—hematologic cancer	0.000129	0.000949	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC35B2—hematologic cancer	0.000127	0.000938	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GBA—hematologic cancer	0.000127	0.000938	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC22A1—hematologic cancer	0.000125	0.000923	CbGpPWpGaD
Entacapone—COMT—Metabolism—CRABP1—hematologic cancer	0.000125	0.000923	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALOX5—hematologic cancer	0.000122	0.000899	CbGpPWpGaD
Entacapone—COMT—Metabolism—NUP98—hematologic cancer	0.000118	0.000871	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTAP—hematologic cancer	0.000116	0.000858	CbGpPWpGaD
Entacapone—COMT—Metabolism—ADCY7—hematologic cancer	0.000115	0.000846	CbGpPWpGaD
Entacapone—COMT—Metabolism—NCOA3—hematologic cancer	0.000115	0.000846	CbGpPWpGaD
Entacapone—COMT—Metabolism—NUP214—hematologic cancer	0.000114	0.00084	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—HRAS—hematologic cancer	0.000112	0.000829	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCG2—hematologic cancer	0.000112	0.000823	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTR—hematologic cancer	0.000112	0.000823	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TGFB1—hematologic cancer	0.00011	0.000811	CbGpPWpGaD
Entacapone—COMT—Metabolism—ENO2—hematologic cancer	0.000109	0.000807	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—hematologic cancer	0.000107	0.000789	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTT1—hematologic cancer	0.000106	0.000782	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—FHL2—hematologic cancer	0.000104	0.000765	CbGpPWpGaD
Entacapone—COMT—Metabolism—SDC1—hematologic cancer	0.000104	0.000765	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AGRN—hematologic cancer	0.000102	0.00075	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HMMR—hematologic cancer	9.64e-05	0.000711	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—IDH2—hematologic cancer	9.64e-05	0.000711	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.09e-05	0.00067	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ARNTL—hematologic cancer	9.06e-05	0.000668	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ACP5—hematologic cancer	8.82e-05	0.00065	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CA9—hematologic cancer	8.82e-05	0.00065	CbGpPWpGaD
Entacapone—COMT—Metabolism—CD44—hematologic cancer	8.82e-05	0.00065	CbGpPWpGaD
Entacapone—COMT—Metabolism—NQO1—hematologic cancer	8.82e-05	0.00065	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NCOR2—hematologic cancer	8.7e-05	0.000642	CbGpPWpGaD
Entacapone—COMT—Neuronal System—HRAS—hematologic cancer	8.61e-05	0.000635	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYCS—hematologic cancer	8.34e-05	0.000615	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—IDH1—hematologic cancer	8.29e-05	0.000611	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSP90AA1—hematologic cancer	8.29e-05	0.000611	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTO1—hematologic cancer	8.2e-05	0.000605	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCC3—hematologic cancer	8.2e-05	0.000605	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—TXN—hematologic cancer	8.2e-05	0.000605	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SPHK1—hematologic cancer	8.02e-05	0.000592	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—UGT1A1—hematologic cancer	7.71e-05	0.000568	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CRABP1—hematologic cancer	7.5e-05	0.000553	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC22A1—hematologic cancer	7.5e-05	0.000553	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTP1—hematologic cancer	7.35e-05	0.000542	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALOX5—hematologic cancer	7.31e-05	0.000539	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NUP98—hematologic cancer	7.08e-05	0.000522	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCB1—hematologic cancer	6.96e-05	0.000513	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ADCY7—hematologic cancer	6.87e-05	0.000507	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NCOA3—hematologic cancer	6.87e-05	0.000507	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NUP214—hematologic cancer	6.82e-05	0.000503	CbGpPWpGaD
Entacapone—COMT—Metabolism—NCOR1—hematologic cancer	6.76e-05	0.000498	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTM1—hematologic cancer	6.76e-05	0.000498	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.75e-05	0.000498	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCG2—hematologic cancer	6.68e-05	0.000493	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTR—hematologic cancer	6.68e-05	0.000493	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ENO2—hematologic cancer	6.55e-05	0.000483	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTT1—hematologic cancer	6.36e-05	0.000469	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.26e-05	0.000462	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SDC1—hematologic cancer	6.21e-05	0.000458	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTHFR—hematologic cancer	5.97e-05	0.00044	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.93e-05	0.000438	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.86e-05	0.000432	CbGpPWpGaD
Entacapone—Alopecia—Epirubicin—hematologic cancer	5.84e-05	7.85e-05	CcSEcCtD
Entacapone—Skin disorder—Prednisone—hematologic cancer	5.83e-05	7.84e-05	CcSEcCtD
Entacapone—Nausea—Gemcitabine—hematologic cancer	5.83e-05	7.84e-05	CcSEcCtD
Entacapone—Vomiting—Cisplatin—hematologic cancer	5.81e-05	7.82e-05	CcSEcCtD
Entacapone—Hyperhidrosis—Prednisone—hematologic cancer	5.8e-05	7.81e-05	CcSEcCtD
Entacapone—Vision blurred—Methotrexate—hematologic cancer	5.79e-05	7.79e-05	CcSEcCtD
Entacapone—Mental disorder—Epirubicin—hematologic cancer	5.79e-05	7.79e-05	CcSEcCtD
Entacapone—Erythema multiforme—Doxorubicin—hematologic cancer	5.78e-05	7.78e-05	CcSEcCtD
Entacapone—Rash—Cisplatin—hematologic cancer	5.76e-05	7.75e-05	CcSEcCtD
Entacapone—Dermatitis—Cisplatin—hematologic cancer	5.76e-05	7.75e-05	CcSEcCtD
Entacapone—Malnutrition—Epirubicin—hematologic cancer	5.75e-05	7.74e-05	CcSEcCtD
Entacapone—Diarrhoea—Etoposide—hematologic cancer	5.73e-05	7.71e-05	CcSEcCtD
Entacapone—Anorexia—Prednisone—hematologic cancer	5.72e-05	7.7e-05	CcSEcCtD
Entacapone—Eye disorder—Doxorubicin—hematologic cancer	5.71e-05	7.69e-05	CcSEcCtD
Entacapone—Ill-defined disorder—Methotrexate—hematologic cancer	5.7e-05	7.67e-05	CcSEcCtD
Entacapone—Feeling abnormal—Betamethasone—hematologic cancer	5.68e-05	7.64e-05	CcSEcCtD
Entacapone—Feeling abnormal—Dexamethasone—hematologic cancer	5.68e-05	7.64e-05	CcSEcCtD
Entacapone—Flushing—Doxorubicin—hematologic cancer	5.67e-05	7.63e-05	CcSEcCtD
Entacapone—Cardiac disorder—Doxorubicin—hematologic cancer	5.67e-05	7.63e-05	CcSEcCtD
Entacapone—Flatulence—Epirubicin—hematologic cancer	5.67e-05	7.62e-05	CcSEcCtD
Entacapone—Tension—Epirubicin—hematologic cancer	5.64e-05	7.59e-05	CcSEcCtD
Entacapone—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.64e-05	7.58e-05	CcSEcCtD
Entacapone—Gastrointestinal pain—Betamethasone—hematologic cancer	5.64e-05	7.58e-05	CcSEcCtD
Entacapone—Dysgeusia—Epirubicin—hematologic cancer	5.63e-05	7.58e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.6e-05	0.000413	CbGpPWpGaD
Entacapone—Hypersensitivity—Triamcinolone—hematologic cancer	5.6e-05	7.53e-05	CcSEcCtD
Entacapone—Nervousness—Epirubicin—hematologic cancer	5.59e-05	7.51e-05	CcSEcCtD
Entacapone—Back pain—Epirubicin—hematologic cancer	5.56e-05	7.48e-05	CcSEcCtD
Entacapone—Malaise—Methotrexate—hematologic cancer	5.54e-05	7.46e-05	CcSEcCtD
Entacapone—Dizziness—Etoposide—hematologic cancer	5.54e-05	7.45e-05	CcSEcCtD
Entacapone—Muscle spasms—Epirubicin—hematologic cancer	5.53e-05	7.44e-05	CcSEcCtD
Entacapone—Vertigo—Methotrexate—hematologic cancer	5.52e-05	7.43e-05	CcSEcCtD
Entacapone—Leukopenia—Methotrexate—hematologic cancer	5.5e-05	7.4e-05	CcSEcCtD
Entacapone—Urticaria—Betamethasone—hematologic cancer	5.48e-05	7.37e-05	CcSEcCtD
Entacapone—Urticaria—Dexamethasone—hematologic cancer	5.48e-05	7.37e-05	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.47e-05	7.36e-05	CcSEcCtD
Entacapone—Dizziness—Prednisolone—hematologic cancer	5.46e-05	7.35e-05	CcSEcCtD
Entacapone—Asthenia—Triamcinolone—hematologic cancer	5.45e-05	7.33e-05	CcSEcCtD
Entacapone—Abdominal pain—Dexamethasone—hematologic cancer	5.45e-05	7.33e-05	CcSEcCtD
Entacapone—Abdominal pain—Betamethasone—hematologic cancer	5.45e-05	7.33e-05	CcSEcCtD
Entacapone—Body temperature increased—Betamethasone—hematologic cancer	5.45e-05	7.33e-05	CcSEcCtD
Entacapone—Body temperature increased—Dexamethasone—hematologic cancer	5.45e-05	7.33e-05	CcSEcCtD
Entacapone—Nausea—Cisplatin—hematologic cancer	5.43e-05	7.3e-05	CcSEcCtD
Entacapone—Insomnia—Prednisone—hematologic cancer	5.43e-05	7.3e-05	CcSEcCtD
Entacapone—Vision blurred—Epirubicin—hematologic cancer	5.42e-05	7.29e-05	CcSEcCtD
Entacapone—Alopecia—Doxorubicin—hematologic cancer	5.4e-05	7.27e-05	CcSEcCtD
Entacapone—Paraesthesia—Prednisone—hematologic cancer	5.39e-05	7.25e-05	CcSEcCtD
Entacapone—Pruritus—Triamcinolone—hematologic cancer	5.37e-05	7.23e-05	CcSEcCtD
Entacapone—Cough—Methotrexate—hematologic cancer	5.36e-05	7.21e-05	CcSEcCtD
Entacapone—Mental disorder—Doxorubicin—hematologic cancer	5.36e-05	7.2e-05	CcSEcCtD
Entacapone—Ill-defined disorder—Epirubicin—hematologic cancer	5.34e-05	7.18e-05	CcSEcCtD
Entacapone—Convulsion—Methotrexate—hematologic cancer	5.33e-05	7.16e-05	CcSEcCtD
Entacapone—Vomiting—Etoposide—hematologic cancer	5.32e-05	7.16e-05	CcSEcCtD
Entacapone—Malnutrition—Doxorubicin—hematologic cancer	5.32e-05	7.16e-05	CcSEcCtD
Entacapone—Agitation—Epirubicin—hematologic cancer	5.29e-05	7.11e-05	CcSEcCtD
Entacapone—Dyspepsia—Prednisone—hematologic cancer	5.28e-05	7.11e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NQO1—hematologic cancer	5.28e-05	0.00039	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CD44—hematologic cancer	5.28e-05	0.00039	CbGpPWpGaD
Entacapone—Rash—Etoposide—hematologic cancer	5.28e-05	7.1e-05	CcSEcCtD
Entacapone—Dermatitis—Etoposide—hematologic cancer	5.28e-05	7.1e-05	CcSEcCtD
Entacapone—Headache—Etoposide—hematologic cancer	5.25e-05	7.06e-05	CcSEcCtD
Entacapone—Flatulence—Doxorubicin—hematologic cancer	5.24e-05	7.05e-05	CcSEcCtD
Entacapone—Myalgia—Methotrexate—hematologic cancer	5.23e-05	7.04e-05	CcSEcCtD
Entacapone—Chest pain—Methotrexate—hematologic cancer	5.23e-05	7.04e-05	CcSEcCtD
Entacapone—Tension—Doxorubicin—hematologic cancer	5.22e-05	7.03e-05	CcSEcCtD
Entacapone—Decreased appetite—Prednisone—hematologic cancer	5.22e-05	7.02e-05	CcSEcCtD
Entacapone—Dysgeusia—Doxorubicin—hematologic cancer	5.21e-05	7.01e-05	CcSEcCtD
Entacapone—Rash—Prednisolone—hematologic cancer	5.21e-05	7.01e-05	CcSEcCtD
Entacapone—Dermatitis—Prednisolone—hematologic cancer	5.2e-05	7e-05	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.2e-05	6.99e-05	CcSEcCtD
Entacapone—Malaise—Epirubicin—hematologic cancer	5.19e-05	6.98e-05	CcSEcCtD
Entacapone—Fatigue—Prednisone—hematologic cancer	5.17e-05	6.96e-05	CcSEcCtD
Entacapone—Headache—Prednisolone—hematologic cancer	5.17e-05	6.96e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.17e-05	0.000381	CbGpPWpGaD
Entacapone—Discomfort—Methotrexate—hematologic cancer	5.17e-05	6.95e-05	CcSEcCtD
Entacapone—Nervousness—Doxorubicin—hematologic cancer	5.17e-05	6.95e-05	CcSEcCtD
Entacapone—Vertigo—Epirubicin—hematologic cancer	5.17e-05	6.95e-05	CcSEcCtD
Entacapone—Syncope—Epirubicin—hematologic cancer	5.16e-05	6.94e-05	CcSEcCtD
Entacapone—Leukopenia—Epirubicin—hematologic cancer	5.15e-05	6.93e-05	CcSEcCtD
Entacapone—Back pain—Doxorubicin—hematologic cancer	5.15e-05	6.92e-05	CcSEcCtD
Entacapone—Constipation—Prednisone—hematologic cancer	5.13e-05	6.9e-05	CcSEcCtD
Entacapone—Muscle spasms—Doxorubicin—hematologic cancer	5.12e-05	6.88e-05	CcSEcCtD
Entacapone—Palpitations—Epirubicin—hematologic cancer	5.08e-05	6.84e-05	CcSEcCtD
Entacapone—Confusional state—Methotrexate—hematologic cancer	5.06e-05	6.8e-05	CcSEcCtD
Entacapone—Loss of consciousness—Epirubicin—hematologic cancer	5.06e-05	6.8e-05	CcSEcCtD
Entacapone—Dizziness—Triamcinolone—hematologic cancer	5.02e-05	6.76e-05	CcSEcCtD
Entacapone—Cough—Epirubicin—hematologic cancer	5.02e-05	6.75e-05	CcSEcCtD
Entacapone—COMT—Metabolism—PIK3CG—hematologic cancer	5.02e-05	0.00037	CbGpPWpGaD
Entacapone—Vision blurred—Doxorubicin—hematologic cancer	5.02e-05	6.75e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CYCS—hematologic cancer	5e-05	0.000369	CbGpPWpGaD
Entacapone—Convulsion—Epirubicin—hematologic cancer	4.98e-05	6.7e-05	CcSEcCtD
Entacapone—Nausea—Etoposide—hematologic cancer	4.97e-05	6.69e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—HSP90AA1—hematologic cancer	4.97e-05	0.000366	CbGpPWpGaD
Entacapone—Hypertension—Epirubicin—hematologic cancer	4.97e-05	6.68e-05	CcSEcCtD
Entacapone—Feeling abnormal—Prednisone—hematologic cancer	4.95e-05	6.65e-05	CcSEcCtD
Entacapone—Asthenia—Betamethasone—hematologic cancer	4.94e-05	6.65e-05	CcSEcCtD
Entacapone—Asthenia—Dexamethasone—hematologic cancer	4.94e-05	6.65e-05	CcSEcCtD
Entacapone—Ill-defined disorder—Doxorubicin—hematologic cancer	4.94e-05	6.64e-05	CcSEcCtD
Entacapone—Nervous system disorder—Methotrexate—hematologic cancer	4.92e-05	6.62e-05	CcSEcCtD
Entacapone—Thrombocytopenia—Methotrexate—hematologic cancer	4.91e-05	6.61e-05	CcSEcCtD
Entacapone—Gastrointestinal pain—Prednisone—hematologic cancer	4.91e-05	6.6e-05	CcSEcCtD
Entacapone—Nausea—Prednisolone—hematologic cancer	4.91e-05	6.6e-05	CcSEcCtD
Entacapone—Myalgia—Epirubicin—hematologic cancer	4.9e-05	6.59e-05	CcSEcCtD
Entacapone—Chest pain—Epirubicin—hematologic cancer	4.9e-05	6.59e-05	CcSEcCtD
Entacapone—Agitation—Doxorubicin—hematologic cancer	4.89e-05	6.58e-05	CcSEcCtD
Entacapone—Anxiety—Epirubicin—hematologic cancer	4.88e-05	6.56e-05	CcSEcCtD
Entacapone—Pruritus—Dexamethasone—hematologic cancer	4.88e-05	6.56e-05	CcSEcCtD
Entacapone—Pruritus—Betamethasone—hematologic cancer	4.88e-05	6.56e-05	CcSEcCtD
Entacapone—Skin disorder—Methotrexate—hematologic cancer	4.87e-05	6.55e-05	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.86e-05	6.54e-05	CcSEcCtD
Entacapone—Hyperhidrosis—Methotrexate—hematologic cancer	4.85e-05	6.52e-05	CcSEcCtD
Entacapone—Discomfort—Epirubicin—hematologic cancer	4.84e-05	6.51e-05	CcSEcCtD
Entacapone—Vomiting—Triamcinolone—hematologic cancer	4.83e-05	6.5e-05	CcSEcCtD
Entacapone—Malaise—Doxorubicin—hematologic cancer	4.8e-05	6.46e-05	CcSEcCtD
Entacapone—Rash—Triamcinolone—hematologic cancer	4.79e-05	6.44e-05	CcSEcCtD
Entacapone—Dry mouth—Epirubicin—hematologic cancer	4.79e-05	6.44e-05	CcSEcCtD
Entacapone—Dermatitis—Triamcinolone—hematologic cancer	4.78e-05	6.44e-05	CcSEcCtD
Entacapone—Vertigo—Doxorubicin—hematologic cancer	4.78e-05	6.43e-05	CcSEcCtD
Entacapone—Anorexia—Methotrexate—hematologic cancer	4.78e-05	6.43e-05	CcSEcCtD
Entacapone—Syncope—Doxorubicin—hematologic cancer	4.77e-05	6.42e-05	CcSEcCtD
Entacapone—Urticaria—Prednisone—hematologic cancer	4.77e-05	6.41e-05	CcSEcCtD
Entacapone—Leukopenia—Doxorubicin—hematologic cancer	4.76e-05	6.41e-05	CcSEcCtD
Entacapone—Headache—Triamcinolone—hematologic cancer	4.76e-05	6.4e-05	CcSEcCtD
Entacapone—Body temperature increased—Prednisone—hematologic cancer	4.74e-05	6.38e-05	CcSEcCtD
Entacapone—Abdominal pain—Prednisone—hematologic cancer	4.74e-05	6.38e-05	CcSEcCtD
Entacapone—Confusional state—Epirubicin—hematologic cancer	4.73e-05	6.37e-05	CcSEcCtD
Entacapone—Diarrhoea—Dexamethasone—hematologic cancer	4.72e-05	6.34e-05	CcSEcCtD
Entacapone—Diarrhoea—Betamethasone—hematologic cancer	4.72e-05	6.34e-05	CcSEcCtD
Entacapone—Palpitations—Doxorubicin—hematologic cancer	4.7e-05	6.33e-05	CcSEcCtD
Entacapone—Oedema—Epirubicin—hematologic cancer	4.69e-05	6.31e-05	CcSEcCtD
Entacapone—Hypotension—Methotrexate—hematologic cancer	4.69e-05	6.31e-05	CcSEcCtD
Entacapone—Loss of consciousness—Doxorubicin—hematologic cancer	4.68e-05	6.29e-05	CcSEcCtD
Entacapone—COMT—Metabolism—CREBBP—hematologic cancer	4.65e-05	0.000343	CbGpPWpGaD
Entacapone—Cough—Doxorubicin—hematologic cancer	4.64e-05	6.25e-05	CcSEcCtD
Entacapone—Shock—Epirubicin—hematologic cancer	4.62e-05	6.21e-05	CcSEcCtD
Entacapone—Convulsion—Doxorubicin—hematologic cancer	4.61e-05	6.2e-05	CcSEcCtD
Entacapone—Nervous system disorder—Epirubicin—hematologic cancer	4.6e-05	6.19e-05	CcSEcCtD
Entacapone—Thrombocytopenia—Epirubicin—hematologic cancer	4.6e-05	6.18e-05	CcSEcCtD
Entacapone—Hypertension—Doxorubicin—hematologic cancer	4.59e-05	6.18e-05	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.57e-05	6.15e-05	CcSEcCtD
Entacapone—Skin disorder—Epirubicin—hematologic cancer	4.56e-05	6.13e-05	CcSEcCtD
Entacapone—Dizziness—Betamethasone—hematologic cancer	4.56e-05	6.13e-05	CcSEcCtD
Entacapone—Dizziness—Dexamethasone—hematologic cancer	4.56e-05	6.13e-05	CcSEcCtD
Entacapone—Hyperhidrosis—Epirubicin—hematologic cancer	4.54e-05	6.1e-05	CcSEcCtD
Entacapone—Insomnia—Methotrexate—hematologic cancer	4.54e-05	6.1e-05	CcSEcCtD
Entacapone—Myalgia—Doxorubicin—hematologic cancer	4.53e-05	6.09e-05	CcSEcCtD
Entacapone—Chest pain—Doxorubicin—hematologic cancer	4.53e-05	6.09e-05	CcSEcCtD
Entacapone—Anxiety—Doxorubicin—hematologic cancer	4.52e-05	6.07e-05	CcSEcCtD
Entacapone—Nausea—Triamcinolone—hematologic cancer	4.51e-05	6.07e-05	CcSEcCtD
Entacapone—Paraesthesia—Methotrexate—hematologic cancer	4.5e-05	6.06e-05	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.5e-05	6.05e-05	CcSEcCtD
Entacapone—Discomfort—Doxorubicin—hematologic cancer	4.48e-05	6.02e-05	CcSEcCtD
Entacapone—Anorexia—Epirubicin—hematologic cancer	4.47e-05	6.02e-05	CcSEcCtD
Entacapone—Dyspnoea—Methotrexate—hematologic cancer	4.47e-05	6.02e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.47e-05	0.00033	CbGpPWpGaD
Entacapone—Somnolence—Methotrexate—hematologic cancer	4.46e-05	6e-05	CcSEcCtD
Entacapone—Dry mouth—Doxorubicin—hematologic cancer	4.43e-05	5.96e-05	CcSEcCtD
Entacapone—Hypersensitivity—Prednisone—hematologic cancer	4.42e-05	5.95e-05	CcSEcCtD
Entacapone—Dyspepsia—Methotrexate—hematologic cancer	4.42e-05	5.94e-05	CcSEcCtD
Entacapone—COMT—Metabolism—PIK3CD—hematologic cancer	4.41e-05	0.000325	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTP1—hematologic cancer	4.41e-05	0.000325	CbGpPWpGaD
Entacapone—Hypotension—Epirubicin—hematologic cancer	4.39e-05	5.9e-05	CcSEcCtD
Entacapone—Vomiting—Betamethasone—hematologic cancer	4.38e-05	5.89e-05	CcSEcCtD
Entacapone—Vomiting—Dexamethasone—hematologic cancer	4.38e-05	5.89e-05	CcSEcCtD
Entacapone—Confusional state—Doxorubicin—hematologic cancer	4.38e-05	5.89e-05	CcSEcCtD
Entacapone—Decreased appetite—Methotrexate—hematologic cancer	4.36e-05	5.87e-05	CcSEcCtD
Entacapone—COMT—Metabolism—ALB—hematologic cancer	4.36e-05	0.000321	CbGpPWpGaD
Entacapone—Rash—Betamethasone—hematologic cancer	4.35e-05	5.85e-05	CcSEcCtD
Entacapone—Rash—Dexamethasone—hematologic cancer	4.35e-05	5.85e-05	CcSEcCtD
Entacapone—Oedema—Doxorubicin—hematologic cancer	4.34e-05	5.84e-05	CcSEcCtD
Entacapone—Dermatitis—Betamethasone—hematologic cancer	4.34e-05	5.84e-05	CcSEcCtD
Entacapone—Dermatitis—Dexamethasone—hematologic cancer	4.34e-05	5.84e-05	CcSEcCtD
Entacapone—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.33e-05	5.83e-05	CcSEcCtD
Entacapone—Fatigue—Methotrexate—hematologic cancer	4.32e-05	5.82e-05	CcSEcCtD
Entacapone—Headache—Dexamethasone—hematologic cancer	4.32e-05	5.81e-05	CcSEcCtD
Entacapone—Headache—Betamethasone—hematologic cancer	4.32e-05	5.81e-05	CcSEcCtD
Entacapone—Asthenia—Prednisone—hematologic cancer	4.31e-05	5.79e-05	CcSEcCtD
Entacapone—Pain—Methotrexate—hematologic cancer	4.29e-05	5.77e-05	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.28e-05	5.75e-05	CcSEcCtD
Entacapone—Shock—Doxorubicin—hematologic cancer	4.27e-05	5.75e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.26e-05	0.000314	CbGpPWpGaD
Entacapone—Nervous system disorder—Doxorubicin—hematologic cancer	4.26e-05	5.73e-05	CcSEcCtD
Entacapone—Thrombocytopenia—Doxorubicin—hematologic cancer	4.25e-05	5.72e-05	CcSEcCtD
Entacapone—Pruritus—Prednisone—hematologic cancer	4.25e-05	5.71e-05	CcSEcCtD
Entacapone—Insomnia—Epirubicin—hematologic cancer	4.25e-05	5.71e-05	CcSEcCtD
Entacapone—Skin disorder—Doxorubicin—hematologic cancer	4.22e-05	5.68e-05	CcSEcCtD
Entacapone—Paraesthesia—Epirubicin—hematologic cancer	4.22e-05	5.67e-05	CcSEcCtD
Entacapone—Hyperhidrosis—Doxorubicin—hematologic cancer	4.2e-05	5.65e-05	CcSEcCtD
Entacapone—Dyspnoea—Epirubicin—hematologic cancer	4.19e-05	5.63e-05	CcSEcCtD
Entacapone—Somnolence—Epirubicin—hematologic cancer	4.17e-05	5.61e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ABCB1—hematologic cancer	4.17e-05	0.000308	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3R1—hematologic cancer	4.17e-05	0.000307	CbGpPWpGaD
Entacapone—Anorexia—Doxorubicin—hematologic cancer	4.14e-05	5.57e-05	CcSEcCtD
Entacapone—Feeling abnormal—Methotrexate—hematologic cancer	4.13e-05	5.56e-05	CcSEcCtD
Entacapone—Dyspepsia—Epirubicin—hematologic cancer	4.13e-05	5.56e-05	CcSEcCtD
Entacapone—Diarrhoea—Prednisone—hematologic cancer	4.11e-05	5.52e-05	CcSEcCtD
Entacapone—Gastrointestinal pain—Methotrexate—hematologic cancer	4.1e-05	5.52e-05	CcSEcCtD
Entacapone—Nausea—Dexamethasone—hematologic cancer	4.09e-05	5.51e-05	CcSEcCtD
Entacapone—Nausea—Betamethasone—hematologic cancer	4.09e-05	5.51e-05	CcSEcCtD
Entacapone—Decreased appetite—Epirubicin—hematologic cancer	4.08e-05	5.49e-05	CcSEcCtD
Entacapone—Hypotension—Doxorubicin—hematologic cancer	4.06e-05	5.46e-05	CcSEcCtD
Entacapone—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.05e-05	5.45e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NCOR1—hematologic cancer	4.05e-05	0.000299	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTM1—hematologic cancer	4.05e-05	0.000299	CbGpPWpGaD
Entacapone—Fatigue—Epirubicin—hematologic cancer	4.05e-05	5.44e-05	CcSEcCtD
Entacapone—Pain—Epirubicin—hematologic cancer	4.01e-05	5.4e-05	CcSEcCtD
Entacapone—Constipation—Epirubicin—hematologic cancer	4.01e-05	5.4e-05	CcSEcCtD
Entacapone—Urticaria—Methotrexate—hematologic cancer	3.98e-05	5.36e-05	CcSEcCtD
Entacapone—Dizziness—Prednisone—hematologic cancer	3.97e-05	5.34e-05	CcSEcCtD
Entacapone—Abdominal pain—Methotrexate—hematologic cancer	3.97e-05	5.33e-05	CcSEcCtD
Entacapone—Body temperature increased—Methotrexate—hematologic cancer	3.97e-05	5.33e-05	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.96e-05	5.32e-05	CcSEcCtD
Entacapone—Insomnia—Doxorubicin—hematologic cancer	3.93e-05	5.28e-05	CcSEcCtD
Entacapone—Paraesthesia—Doxorubicin—hematologic cancer	3.9e-05	5.25e-05	CcSEcCtD
Entacapone—Dyspnoea—Doxorubicin—hematologic cancer	3.87e-05	5.21e-05	CcSEcCtD
Entacapone—Feeling abnormal—Epirubicin—hematologic cancer	3.87e-05	5.2e-05	CcSEcCtD
Entacapone—Somnolence—Doxorubicin—hematologic cancer	3.86e-05	5.19e-05	CcSEcCtD
Entacapone—COMT—Metabolism—PIK3CB—hematologic cancer	3.85e-05	0.000284	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Epirubicin—hematologic cancer	3.84e-05	5.16e-05	CcSEcCtD
Entacapone—Dyspepsia—Doxorubicin—hematologic cancer	3.82e-05	5.14e-05	CcSEcCtD
Entacapone—Vomiting—Prednisone—hematologic cancer	3.82e-05	5.13e-05	CcSEcCtD
Entacapone—Rash—Prednisone—hematologic cancer	3.78e-05	5.09e-05	CcSEcCtD
Entacapone—Dermatitis—Prednisone—hematologic cancer	3.78e-05	5.09e-05	CcSEcCtD
Entacapone—Decreased appetite—Doxorubicin—hematologic cancer	3.78e-05	5.08e-05	CcSEcCtD
Entacapone—Headache—Prednisone—hematologic cancer	3.76e-05	5.06e-05	CcSEcCtD
Entacapone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.75e-05	5.04e-05	CcSEcCtD
Entacapone—Fatigue—Doxorubicin—hematologic cancer	3.74e-05	5.04e-05	CcSEcCtD
Entacapone—Urticaria—Epirubicin—hematologic cancer	3.73e-05	5.02e-05	CcSEcCtD
Entacapone—Constipation—Doxorubicin—hematologic cancer	3.71e-05	5e-05	CcSEcCtD
Entacapone—Pain—Doxorubicin—hematologic cancer	3.71e-05	5e-05	CcSEcCtD
Entacapone—Body temperature increased—Epirubicin—hematologic cancer	3.71e-05	4.99e-05	CcSEcCtD
Entacapone—Abdominal pain—Epirubicin—hematologic cancer	3.71e-05	4.99e-05	CcSEcCtD
Entacapone—Hypersensitivity—Methotrexate—hematologic cancer	3.7e-05	4.97e-05	CcSEcCtD
Entacapone—Asthenia—Methotrexate—hematologic cancer	3.6e-05	4.84e-05	CcSEcCtD
Entacapone—Feeling abnormal—Doxorubicin—hematologic cancer	3.58e-05	4.81e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—MTHFR—hematologic cancer	3.58e-05	0.000264	CbGpPWpGaD
Entacapone—Nausea—Prednisone—hematologic cancer	3.57e-05	4.8e-05	CcSEcCtD
Entacapone—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.55e-05	4.78e-05	CcSEcCtD
Entacapone—Pruritus—Methotrexate—hematologic cancer	3.55e-05	4.77e-05	CcSEcCtD
Entacapone—Hypersensitivity—Epirubicin—hematologic cancer	3.46e-05	4.65e-05	CcSEcCtD
Entacapone—Urticaria—Doxorubicin—hematologic cancer	3.45e-05	4.64e-05	CcSEcCtD
Entacapone—Body temperature increased—Doxorubicin—hematologic cancer	3.43e-05	4.62e-05	CcSEcCtD
Entacapone—Abdominal pain—Doxorubicin—hematologic cancer	3.43e-05	4.62e-05	CcSEcCtD
Entacapone—Diarrhoea—Methotrexate—hematologic cancer	3.43e-05	4.62e-05	CcSEcCtD
Entacapone—Asthenia—Epirubicin—hematologic cancer	3.37e-05	4.53e-05	CcSEcCtD
Entacapone—COMT—Metabolism—PTEN—hematologic cancer	3.32e-05	0.000245	CbGpPWpGaD
Entacapone—Pruritus—Epirubicin—hematologic cancer	3.32e-05	4.47e-05	CcSEcCtD
Entacapone—Dizziness—Methotrexate—hematologic cancer	3.32e-05	4.46e-05	CcSEcCtD
Entacapone—Diarrhoea—Epirubicin—hematologic cancer	3.21e-05	4.32e-05	CcSEcCtD
Entacapone—Hypersensitivity—Doxorubicin—hematologic cancer	3.2e-05	4.3e-05	CcSEcCtD
Entacapone—Vomiting—Methotrexate—hematologic cancer	3.19e-05	4.29e-05	CcSEcCtD
Entacapone—COMT—Metabolism—EP300—hematologic cancer	3.17e-05	0.000234	CbGpPWpGaD
Entacapone—Rash—Methotrexate—hematologic cancer	3.16e-05	4.25e-05	CcSEcCtD
Entacapone—Dermatitis—Methotrexate—hematologic cancer	3.16e-05	4.25e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.15e-05	0.000233	CbGpPWpGaD
Entacapone—Headache—Methotrexate—hematologic cancer	3.14e-05	4.23e-05	CcSEcCtD
Entacapone—Asthenia—Doxorubicin—hematologic cancer	3.12e-05	4.19e-05	CcSEcCtD
Entacapone—Dizziness—Epirubicin—hematologic cancer	3.1e-05	4.18e-05	CcSEcCtD
Entacapone—Pruritus—Doxorubicin—hematologic cancer	3.07e-05	4.13e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PIK3CG—hematologic cancer	3.01e-05	0.000222	CbGpPWpGaD
Entacapone—Vomiting—Epirubicin—hematologic cancer	2.98e-05	4.01e-05	CcSEcCtD
Entacapone—Nausea—Methotrexate—hematologic cancer	2.98e-05	4.01e-05	CcSEcCtD
Entacapone—Diarrhoea—Doxorubicin—hematologic cancer	2.97e-05	4e-05	CcSEcCtD
Entacapone—Rash—Epirubicin—hematologic cancer	2.96e-05	3.98e-05	CcSEcCtD
Entacapone—Dermatitis—Epirubicin—hematologic cancer	2.96e-05	3.98e-05	CcSEcCtD
Entacapone—Headache—Epirubicin—hematologic cancer	2.94e-05	3.96e-05	CcSEcCtD
Entacapone—Dizziness—Doxorubicin—hematologic cancer	2.87e-05	3.86e-05	CcSEcCtD
Entacapone—Nausea—Epirubicin—hematologic cancer	2.79e-05	3.75e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CREBBP—hematologic cancer	2.79e-05	0.000206	CbGpPWpGaD
Entacapone—Vomiting—Doxorubicin—hematologic cancer	2.76e-05	3.71e-05	CcSEcCtD
Entacapone—Rash—Doxorubicin—hematologic cancer	2.74e-05	3.68e-05	CcSEcCtD
Entacapone—Dermatitis—Doxorubicin—hematologic cancer	2.74e-05	3.68e-05	CcSEcCtD
Entacapone—Headache—Doxorubicin—hematologic cancer	2.72e-05	3.66e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PIK3CD—hematologic cancer	2.64e-05	0.000195	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALB—hematologic cancer	2.61e-05	0.000192	CbGpPWpGaD
Entacapone—Nausea—Doxorubicin—hematologic cancer	2.58e-05	3.47e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PIK3R1—hematologic cancer	2.5e-05	0.000184	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CA—hematologic cancer	2.34e-05	0.000173	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CB—hematologic cancer	2.3e-05	0.00017	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTEN—hematologic cancer	1.99e-05	0.000147	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKT1—hematologic cancer	1.92e-05	0.000141	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—EP300—hematologic cancer	1.9e-05	0.00014	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CA—hematologic cancer	1.4e-05	0.000104	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKT1—hematologic cancer	1.15e-05	8.46e-05	CbGpPWpGaD
